UQCRC1

Chr 3AD

ubiquinol-cytochrome c reductase core protein 1

Also known as: D3S3191, PKNPY, QCR1, UQCR1

Enables ubiquitin protein ligase binding activity. Predicted to be involved in oxidative phosphorylation. Predicted to act upstream of or within mitochondrial electron transport, ubiquinol to cytochrome c. Located in mitochondrial inner membrane. Implicated in Alzheimer's disease. Biomarker of Alzheimer's disease. [provided by Alliance of Genome Resources, Apr 2025]

GeneReviewsOMIMResearchGenerating clinical summary…

Primary Disease Associations & Inheritance

Parkinsonism with polyneuropathyMIM #619279
AD

Clinical highlights

Gene-disease validity (ClinGen)
mitochondrial disease · ADDisputedevidence questions this relationship
Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
1
Active trials
44
Pubs (1 yr)
P/LP submissions
P/LP missense
0.55
LOEUF
DN
Mechanism· predicted
📖
GeneReview available — UQCRC1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.55LOEUF
pLI 0.020
Z-score 3.32
OE 0.30 (0.180.55)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
0.56Z-score
OE missense 0.91 (0.821.01)
275 obs / 302.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.30 (0.180.55)
00.351.4
Missense OE?0.91 (0.821.01)
00.61.4
Synonymous OE?1.13
01.21.6
LoF obs/exp: 8 / 26.4Missense obs/exp: 275 / 302.2Syn Z: -1.07

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

UQCRC1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.